𝔖 Bobbio Scriptorium
✦   LIBER   ✦

“Sleep benefit” in Parkinson's disease: A systematic review

✍ Scribed by van Gilst, Merel M.; Bloem, Bastiaan R.; Overeem, Sebastiaan


Book ID
120221615
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
208 KB
Volume
19
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Sleep benefit in parkinson's disease
✍ Dr. Marcelo Merello; Andrew Hughes; Carlo Colosimo; Marion Hoffman; Sergio Stark 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB

## Abstract Sleep benefit (SB) In Parkinson's disease (PD) is not well characterized. To determine SB frequency, as well as to characterize and correlate it with other disease variables, we evaluated prospectively a consecutive series of 312 PD patients by means of a structured questionnaire: 55% r

Parkinson's disease in Arabs: A systemat
✍ Hani T.S. Benamer; Rajith de Silva; Khurram A. Siddiqui; Donald G. Grosset 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

## Abstract Studies of specific populations have provided invaluable knowledge about Parkinson's disease (PD), especially in the field of genetics. The present report systematically reviews the medical literature on PD in Arabs. Medline and Embase were searched, and 24 article were identified: gene

Emotional processing in Parkinson's dise
✍ Julie Péron; Thibaut Dondaine; Florence Le Jeune; Didier Grandjean; Marc Vérin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 810 KB

## Abstract Parkinson's disease provides a useful model for studying the neural substrates of emotional processing. The striato‐thalamo‐cortical circuits, like the mesolimbic dopamine system that modulates their function, are thought to be involved in emotional processing. As Parkinson's disease is

Neuroprotection trials in Parkinson's di
✍ Robert G. Hart; Lesly A. Pearce; Bernard M. Ravina; Toby C. Yaltho; John R. Marl 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract Treatments to slow the progression are a major unmet need in Parkinson's disease. Detailed assessment of randomized trials testing putative neuroprotective drugs was undertaken to inform the design, reporting, and interpretation of future studies. This study is a systematic review of tr